Tag: phase 2 trial
September 3, 2019
Aridis Tumbles After Phase 2 Trial Fails to Meet Endpoint
Aridis Pharmaceuticals dipped more than 6 percent on the news that AR-105 did not meet its primary endpoint in a... September 3, 2019
Concert Pharmaceuticals Reports Positive CTP-543 Results
Concert Pharmaceuticals (NASDAQ:CNCE) has announced topline results from its Phase 2 trial evaluating CTP-543 in patients with moderate-to-severe alopecia areata.... August 27, 2019
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products
Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that it and Noile-Immune Biotech will co-develop SPEAR T-cell products based on the co-expression of... August 26, 2019
Bio-Path Doses Patient in Amended Phase 2 Prexigebersen Trial
Bio-Path Holdings (NASDAQ:BPTH) has announced patient dosing in its amended Phase 2 trial of prexigebersen to treat acute myeloid leukemia... March 6, 2019
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Bio-Path Holdings (NASDAQ:BPTH) has announced a clinical update on its interim analysis from the Phase 2 trial of prexigebersen (BP1001)...
November 27, 2018
G1 Therapeutics Releases Phase 2 Data
Trilaciclib was tested in combination with chemotherapy and the checkpoint inhibitor Tecentriq in first-line small cell lung cancer patients. November 27, 2018